Medicine Crosses the Line: The FDA's 2026 Reset for Patient-Facing AI

Name: The FDA's 2026 AI Pathway: $150M, CMS ACCESS & TEMPO
Uploaded: 2026-07-14T19:08:01.414Z
Description: Over $150M in funding, the CMS ACCESS Medicare model, and the FDA's TEMPO pilot made 2026 the year regulated patient-facing clinical AI became shippable. UpDoc is the proof.

July 14, 2026

In 2026 the FDA cleared the first clinical language model allowed to speak directly with a patient. A fresh funding wave and a new Medicare pathway show that regulated, voice-first healthcare AI is now shippable.

Read the full article

Video: The FDA's 2026 AI Pathway: $150M, CMS ACCESS & TEMPO